Literature DB >> 36260275

The correlation of CD70 in immune characteristics and drug therapy of pan-cancer.

Yang Yang1,2, Jinghong Chen3, Mingyang Feng1,2, Yujiao Wang4, Weiting Liao1,2, Qiuji Wu1,2, Feng Wen1,2, Qiu Li5,6.   

Abstract

Entities:  

Year:  2022        PMID： 36260275     DOI： 10.1007/s13577-022-00786-2

Source DB:  PubMed          Journal:  Hum Cell        ISSN： 0914-7470            Impact factor:   4.374


× No keyword cloud information.
  7 in total

1.  Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents.

Authors:  Carsten Riether; Thomas Pabst; Sabine Höpner; Ulrike Bacher; Magdalena Hinterbrandner; Yara Banz; Rouven Müller; Markus G Manz; Walid H Gharib; David Francisco; Remy Bruggmann; Luc van Rompaey; Mahan Moshir; Tim Delahaye; Domenica Gandini; Ellen Erzeel; Anna Hultberg; Samson Fung; Hans de Haard; Nicolas Leupin; Adrian F Ochsenbein
Journal:  Nat Med       Date:  2020-06-29       Impact factor: 53.440

2.  TNF plays a crucial role in inflammation by signaling via T cell TNFR2.

Authors:  Muhammad S Alam; Shizuka Otsuka; Nathan Wong; Aamna Abbasi; Matthias M Gaida; Yu Fan; Daoud Meerzaman; Jonathan D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

Review 3.  The CD70-CD27 axis in oncology: the new kids on the block.

Authors:  Tal Flieswasser; Astrid Van den Eynde; Jonas Van Audenaerde; Jorrit De Waele; Filip Lardon; Carsten Riether; Hans de Haard; Evelien Smits; Patrick Pauwels; Julie Jacobs
Journal:  J Exp Clin Cancer Res       Date:  2022-01-06

4.  CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.

Authors:  Mathieu Seyfrid; William Thomas Maich; Vaseem Muhammad Shaikh; Nazanin Tatari; Deepak Upreti; Deween Piyasena; Minomi Subapanditha; Neil Savage; Dillon McKenna; Nicholas Mikolajewicz; Hong Han; Chirayu Chokshi; Laura Kuhlmann; Amanda Khoo; Sabra Khalid Salim; Blessing Archibong-Bassey; William Gwynne; Kevin Brown; Nadeem Murtaza; David Bakhshinyan; Parvez Vora; Chitra Venugopal; Jason Moffat; Thomas Kislinger; Sheila Singh
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

Review 5.  Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches.

Authors:  Punit Saraon; Shivanthy Pathmanathan; Jamie Snider; Anna Lyakisheva; Victoria Wong; Igor Stagljar
Journal:  Oncogene       Date:  2021-06-02       Impact factor: 9.867

Review 6.  New emerging targets in cancer immunotherapy: CD27 (TNFRSF7).

Authors:  Angelika M Starzer; Anna S Berghoff
Journal:  ESMO Open       Date:  2020-03

7.  CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer.

Authors:  Mayu Shiomi; Shinya Matsuzaki; Satoshi Serada; Koji Matsuo; Chihiro Mizuta-Odani; Mariko Jitsumori; Ruriko Nakae; Satoko Matsuzaki; Satoshi Nakagawa; Kosuke Hiramatsu; Ai Miyoshi; Eiji Kobayashi; Toshihiro Kimura; Yutaka Ueda; Kiyoshi Yoshino; Tetsuji Naka; Tadashi Kimura
Journal:  Cancer Sci       Date:  2021-06-12       Impact factor: 6.716
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.